Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

788
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
788
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

5.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.3K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

1.2K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.2K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

2.3K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond neutrality: reassessing diabetes as a modulator in stress cardiomyopathy.

Postgraduate medicine·2025
Same author

Editorial: Simultaneous extracorporeal membrane oxygenation and Impella: Synergy or contrariety?

Cardiovascular revascularization medicine : including molecular interventions·2024
Same author

A Case Of Takotsubo Syndrome Precipitated By Diabetic Ketoacidosis.

Journal of Ayub Medical College, Abbottabad : JAMC·2024
Same author

Hydrogen Water: Extra Healthy or a Hoax?-A Systematic Review.

International journal of molecular sciences·2024
Same author

Heartfelt Breakthroughs: Elevating Quality of Life with Cutting-Edge Advances in Heart Failure Treatment.

Journal of cardiovascular development and disease·2024
Same author

Artificial intelligence in sleep medicine: Present and future.

World journal of clinical cases·2023

Related Experiment Video

Updated: Apr 29, 2026

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment
04:29

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment

Published on: June 30, 2023

1.9K

Interatrial block in the modern era.

Lovely Chhabra, Ramprakash Devadoss, Vinod K Chaubey

  • 180 Seymour Street, Hartford, CT (06102), USA. lovids@hotmail.com.

Current Cardiology Reviews
|May 16, 2014
PubMed
Summary

Interatrial block (IAB), a common heart rhythm issue causing atrial conduction delay, is often overlooked. This condition, linked to atrial fibrillation and stroke, requires further research for better management.

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.9K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Related Experiment Videos

Last Updated: Apr 29, 2026

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment
04:29

Author Spotlight: Advancements in Intracardiac Echocardiography for Atrial Anatomy Assessment

Published on: June 30, 2023

1.9K
Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

2.9K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.6K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Internal Medicine

Background:

  • Interatrial block (IAB), defined by prolonged P-wave duration (≥ 110 ms), signifies delayed conduction between the atria.
  • IAB is a prevalent yet underrecognized conduction abnormality in clinical practice, often inadequately covered in cardiology education.
  • This condition exhibits variable degrees and morphologies, with potential for progression to higher-degree blocks or transient manifestation.

Purpose of the Study:

  • To highlight the clinical significance and underappreciation of Interatrial Block (IAB).
  • To discuss the association of IAB with atrial arrhythmias and other clinical conditions.
  • To emphasize the need for further research and standardized management strategies for IAB.

Main Methods:

  • Review of existing medical literature on Interatrial Block (IAB).
  • Analysis of P-wave duration and morphology for IAB classification.
  • Correlation of IAB with atrial arrhythmias and clinical abnormalities.

Main Results:

  • IAB is a pandemic conduction abnormality frequently underappreciated in clinical practice.
  • IAB is associated with increased risk of atrial arrhythmias, particularly atrial fibrillation.
  • IAB is linked to left atrial dilation, thromboembolism, embolic stroke, and mesenteric ischemia.

Conclusions:

  • Interatrial Block (IAB) warrants greater clinical attention due to its significant associations.
  • Prospective studies are essential to establish consensus on IAB diagnosis and management.
  • Further research is needed to understand the full clinical impact and optimize treatment strategies for IAB.